chr19-45352801-C-G
Variant summary
Our verdict is Pathogenic. The variant received 18 ACMG points: 18P and 0B. PS3PM5PP3_StrongPP5_Very_Strong
The NM_000400.4(ERCC2):c.1847G>C(p.Arg616Pro) variant causes a missense change. The variant allele was found at a frequency of 0.000283 in 1,613,336 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★). ClinVar reports functional evidence for this variant: "SCV000413569: Taylor et al. (1997) demonstrated that the p.Arg616Pro variant was unable to rescue lethality in a yeast complementation assay. When compared to control cell lines exposed to UV, fibroblasts from individuals carrying the p.Arg616Pro variant showed greater levels of apoptosis (Quielle et al. 2001) and reduced nucleotide excision repair capacity (Shafer et al. 2013), and the variant was noted to completely abolish basal transcription (Dubaele et al. 2003).; SCV000577052: Published functional studies on the yeast Rad15 gene, which is homologous to the human ERCC2 gene, demonstrate that the yeast R616P homologous variant is a functional null allele (PMID:9238033);; SCV001578448: Experimental studies have shown that this missense change affects ERCC2 function (PMID:9238033, 12820975).; SCV001365778: In vitro functional studies support an impact on protein function (Taylor 1997, Queille 2001, Dubaele 2003).; SCV001370738: Experimental studies have shown that the variant completely abolished basal transcription, failed to restore viability, and abolished more than 80% of excision repair activity (Dubaele_2003, Taylor_1997, Broughton_1994).; SCV003749556: In vitro studies of the homolog rad15 suggests this mutation is a null allele when it was observed that this mutation could not restore cell viability when compound heterozygous with a deletion mutation (Taylor, 1997).; SCV006324584: Functional studies have shown that this variant decreases repair activity (PMID:9238033, 23800062) (PS3).". Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R616Q) has been classified as Likely pathogenic.
Frequency
Consequence
NM_000400.4 missense
Scores
Clinical Significance
Conservation
Publications
- cerebrooculofacioskeletal syndrome 2Inheritance: AR Classification: DEFINITIVE Submitted by: G2P
- trichothiodystrophy 1, photosensitiveInheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Illumina, Genomics England PanelApp, G2P, Labcorp Genetics (formerly Invitae)
- xeroderma pigmentosum group DInheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Genomics England PanelApp, ClinGen, Labcorp Genetics (formerly Invitae), Laboratory for Molecular Medicine, G2P
- sarcomaInheritance: AR Classification: MODERATE Submitted by: Genomics England PanelApp
- COFS syndromeInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
- trichothiodystrophyInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
- xeroderma pigmentosumInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
- xeroderma pigmentosum-Cockayne syndrome complexInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 18 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_000400.4. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Sel. | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| ERCC2 | MANE Select | c.1847G>C | p.Arg616Pro | missense | Exon 20 of 23 | NP_000391.1 | P18074-1 | ||
| ERCC2 | c.1775G>C | p.Arg592Pro | missense | Exon 20 of 23 | NP_001427284.1 | ||||
| ERCC2 | c.1769G>C | p.Arg590Pro | missense | Exon 19 of 22 | NP_001427285.1 |
Ensembl Transcripts
| Sel. | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| ERCC2 | TSL:1 MANE Select | c.1847G>C | p.Arg616Pro | missense | Exon 20 of 23 | ENSP00000375809.4 | P18074-1 | ||
| ERCC2 | TSL:1 | c.1847G>C | p.Arg616Pro | missense | Exon 20 of 22 | ENSP00000375808.4 | E7EVE9 | ||
| ERCC2 | TSL:1 | c.1775G>C | p.Arg592Pro | missense | Exon 19 of 21 | ENSP00000375805.2 | A8MX75 |
Frequencies
GnomAD3 genomes AF: 0.000145 AC: 22AN: 151734Hom.: 0 Cov.: 31 show subpopulations
GnomAD2 exomes AF: 0.000151 AC: 38AN: 250892 AF XY: 0.000125 show subpopulations
GnomAD4 exome AF: 0.000297 AC: 434AN: 1461602Hom.: 0 Cov.: 37 AF XY: 0.000268 AC XY: 195AN XY: 727080 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.000145 AC: 22AN: 151734Hom.: 0 Cov.: 31 AF XY: 0.000121 AC XY: 9AN XY: 74092 show subpopulations
Age Distribution
ClinVar
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at